Literature DB >> 30863610

Society for Translational Medicine Expert consensus on the selection of surgical approaches in the management of thoracic esophageal carcinoma.

Yousheng Mao1, Zhentao Yu2, Bin You3, Wentao Fang4, Brian Badgwell5, Mark F Berry6, DuyKhanh P Ceppa7, Chun Chen8, Haiquan Chen4,9, Miguel A Cuesta10, Xavier Benoit D'Journo11, Guy D Eslick12, Jianhua Fu13, Xiangning Fu14, Shugeng Gao1, Jianxing He15,16, Jie He1, Yunchao Huang17, Gening Jiang18, Zhongmin Jiang19, Jae Y Kim20, Danqing Li21, Hui Li3, Shanqing Li22, Deruo Liu23, Lunxu Liu24, Yongyu Liu25, Xiaofei Li26, Yin Li27, Weimin Mao28, Daniela Molena29, Christopher R Morse30, Nuria M Novoa31, Lijie Tan32, Qunyou Tan33, Alper Toker34, Ti Tong35, Qun Wang32, Benny Weksler36, Lin Xu37, Shidong Xu38, Tiansheng Yan39, Lanjun Zhang13, Xingyi Zhang35, Xun Zhang40, Zhu Zhang41, Xiuyi Zhi42, Qinghua Zhou43.   

Abstract

Entities:  

Year:  2019        PMID： 30863610      PMCID： PMC6384330          DOI： 10.21037/jtd.2018.12.07

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  35 in total

1.  [Influence of the number of lymph node metastasis on survival and significance of postoperative radiotherapy for esophageal carcinoma].

Authors:  Ze-fen Xiao; Zong-yi Yang; Lü-hua Wang; Hong-xing Zhang; Qin-fu Feng; Dong-fu Chen; Zong-mei Zhou; De-chao Zhang; Ke-lin Sun; Gui-yu Cheng; Jie He
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2004-02

2.  Lymphadenectomy extent is closely related to long-term survival in esophageal cancer.

Authors:  Chang Hyun Kang; Young Tae Kim; Sang-Hoon Jeon; Sook-Whan Sung; Joo Hyun Kim
Journal:  Eur J Cardiothorac Surg       Date:  2006-12-04       Impact factor: 4.191

3.  Minimally invasive esophagectomy: thoracoscopic mobilization of the esophagus and mediastinal lymphadenectomy in prone position--experience of 130 patients.

Authors:  Chinnusamy Palanivelu; Anand Prakash; Rangaswamy Senthilkumar; Palanisamy Senthilnathan; Ramakrishnan Parthasarathi; Pidigu Seshiyer Rajan; S Venkatachlam
Journal:  J Am Coll Surg       Date:  2006-07       Impact factor: 6.113

4.  Impact of the number and extent of positive lymph nodes in 200 patients with thoracic esophageal squamous cell carcinoma after three-field lymph node dissection.

Authors:  Hideaki Shimada; Shin-ichi Okazumi; Hisahiro Matsubara; Yoshihiro Nabeya; Tooru Shiratori; Takanori Shimizu; Kiyohiko Shuto; Hideki Hayashi; Takenori Ochiai
Journal:  World J Surg       Date:  2006-08       Impact factor: 3.352

5.  Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies.

Authors:  J A Hagen; S R DeMeester; J H Peters; P Chandrasoma; T R DeMeester
Journal:  Ann Surg       Date:  2001-10       Impact factor: 12.969

6.  Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus.

Authors:  Nasser Altorki; Michael Kent; Cathy Ferrara; Jeffrey Port
Journal:  Ann Surg       Date:  2002-08       Impact factor: 12.969

7.  The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection.

Authors:  Christian G Peyre; Jeffrey A Hagen; Steven R DeMeester; Nasser K Altorki; Ermanno Ancona; S Michael Griffin; Arnulf Hölscher; Toni Lerut; Simon Law; Thomas W Rice; Alberto Ruol; Jan J B van Lanschot; John Wong; Tom R DeMeester
Journal:  Ann Surg       Date:  2008-10       Impact factor: 12.969

8.  Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial.

Authors:  Jikke M T Omloo; Sjoerd M Lagarde; Jan B F Hulscher; Johannes B Reitsma; Paul Fockens; Herman van Dekken; Fiebo J W Ten Kate; Huug Obertop; Hugo W Tilanus; J Jan B van Lanschot
Journal:  Ann Surg       Date:  2007-12       Impact factor: 12.969

9.  Prediction of lymph node status in superficial esophageal carcinoma.

Authors:  Ermanno Ancona; Sabrina Rampado; Mauro Cassaro; Giorgio Battaglia; Alberto Ruol; Carlo Castoro; Giuseppe Portale; Francesco Cavallin; Massimo Rugge
Journal:  Ann Surg Oncol       Date:  2008-08-26       Impact factor: 5.344

10.  Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.

Authors:  David Cunningham; William H Allum; Sally P Stenning; Jeremy N Thompson; Cornelis J H Van de Velde; Marianne Nicolson; J Howard Scarffe; Fiona J Lofts; Stephen J Falk; Timothy J Iveson; David B Smith; Ruth E Langley; Monica Verma; Simon Weeden; Yu Jo Chua
Journal:  N Engl J Med       Date:  2006-07-06       Impact factor: 91.245
View more
  4 in total

1.  Ubiquitination of NOTCH2 by DTX3 suppresses the proliferation and migration of human esophageal carcinoma.

Authors:  Xin-Yu Ding; Hai-Yang Hu; Ke-Nan Huang; Rong-Qiang Wei; Jie Min; Chen Qi; Hua Tang; Xiong Qin
Journal:  Cancer Sci       Date:  2020-02       Impact factor: 6.716

Review 2.  Radical minimally invasive esophagectomy for esophageal cancer via transcervical and transhiatal approaches: a narrative review.

Authors:  Zheng Wang; Rongjie Yang
Journal:  J Thorac Dis       Date:  2021-08       Impact factor: 2.895

3.  Efficacy and safety of esophagectomy via left thoracic approach versus via right thoracic approach for middle and lower thoracic esophageal cancer: a multicenter randomized clinical trial (NST1501).

Authors:  You-Sheng Mao; Shu-Geng Gao; Yin Li; An-Lin Hao; Jun-Feng Liu; Xiao-Fei Li; Tie-Hua Rong; Jian-Hua Fu; Jian-Qun Ma; Mei-Qing Xu; Ren-Quan Zhang; Gao-Ming Xiao; Xiang-Ning Fu; Ke-Neng Chen; Wei-Min Mao; Yong-Yu Liu; Hong-Xu Liu; Zhi-Rong Zhang; Yan Fang; Dong-Hong Fu; Xu-Dong Wei; Li-Gong Yuan; Shan Muhammad; Wen-Qiang Wei; Philip Wai-Yan Chiu; Shane Lloyd; Francisco Schlottmann; Kenneth Meredith; Jose M Pimiento; Yi-Bo Gao; Jie He
Journal:  Ann Transl Med       Date:  2022-08

4.  A Retrospective Study of 52 Patients With Primary Small Cell Carcinoma of the Esophagus Treated With Radical Surgery.

Authors:  Ningbo Fan; Zhen Wang; Yuanheng Huang; Zihui Tan; Han Yang; Peng Lin
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.